Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001178913-26-005168·SOPHiA GENETICS SA
Schedule 13D ownership disclosure
SOPHIA GENETICS SA
Ordinary Shares, par value CHF 0.05 per share · CUSIP: H82027105
Event date: 2026-11-10
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Schindel Yair ChaimReported CIK 0001823758
Shares: 5,318,023.00 · Class: 6.2%
- aMoon Growth Fund Limited Partnership
Shares: 5,318,023.00 · Class: 6.2%
- aMoon Growth Fund G.P. Limited Partnership
Shares: 5,318,023.00 · Class: 6.2%
- aMoon General Partner Ltd.
Shares: 5,318,023.00 · Class: 6.2%
- aMoon Edge Limited Partnership
Shares: 0.00 · Class: 0%
- aMoon Edge GP Ltd.
Shares: 0.00 · Class: 0%
- Hilliyon Holdings Ltd.
Shares: 0.00 · Class: 0%
- Berko Capital Ltd.
Shares: 0.00 · Class: 0%
- Dr. Tomer Berkovitz
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001178913-26-005168
- Form type
- SCHEDULE 13D/A
- Filer
- SOPHiA GENETICS SA
- CIK
- CIK 1840706
- Filed
- Nov 12, 2026
- Reporting period
- Nov 10, 2026
- Description
- Schedule 13D beneficial ownership